Regulatory B cell-myeloma cell interaction confers immunosuppression and promotes their survival in the bone marrow milieu

Blood Cancer J. 2017 Mar 24;7(3):e547. doi: 10.1038/bcj.2017.24.

L Zhang^{1

2}, Y-T Tai¹, M Ho^{1

3}, L Xing¹, D Chauhan¹, A Gang^{1

4}, L Qiu⁴, K C Anderson¹

¹ LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
² Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.
³ UCD School of Medicine, College of Health and Agricultural Science and UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, UCD, Dublin 4, Ireland.
⁴ State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China.

No abstract available

Publication types